Archive · 28 Jul 2025
NephroPlus Files for ₹353.4 Crore IPO to Expand Dialysis Clinics
A company called NephroPlus, which helps people with kidney problems, is planning to sell shares of their company to the public through something called an IPO.
They are aiming to collect around ₹353.4 crore to open more kidney care centers across India, pay back some loans, and cover general company expenses.
NephroPlus already runs many dialysis clinics in India and also has clinics in some other countries, helping thousands of patients.
Nephrocare Health Services, operating as NephroPlus, filed for an IPO to raise ₹353.4 crore.
The IPO includes both a fresh issue of equity shares and an offer-for-sale of existing shares.
Funds will be used for expanding dialysis clinics in India, debt repayment, and general corporate purposes.
NephroPlus is Asia's largest dialysis service provider and the fifth-largest globally.
The company operates clinics in India and several other countries including Philippines, Uzbekistan, Nepal, and Saudi Arabia.
- Who
- Nephrocare Health Services, known as NephroPlus, is the parent company.
- What
- Nephrocare Health Services, doing business as NephroPlus, filed for an IPO.
- When
- The filing occurred recently.
- Where
- Hyderabad, India, and dialysis clinics across India, Philippines, Uzbekistan, Nepal, and Saudi Arabia.
- Why
- To raise funds for domestic expansion, debt repayment, and general corporate purposes.
- Company
- Nephrocare Health Services (NephroPlus)
- IPO Amount
- ₹353.4 crore
- Use of Funds
- New clinics, debt repayment, and general corporate purposes
- Subsidiary
- NephroPlus
- Clinics in India
- 447
- Countries of Operation
- India, Philippines, Uzbekistan, Nepal, Saudi Arabia
- FY25 Revenue
- ₹755.8 crore
- FY25 Profit After Tax
- ₹67 crore
